证券代码：603685 证券简称：晨丰科技 公告编号：2025-033 债券代码：113628 债券简称：晨丰转债 浙江晨丰科技股份有限公司 关于 2024 年年度权益分派实施后调整向特定对象发 行股票发行价格和募集资金总额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 浙江晨丰科技股份有限公司（以下简称"公司" "晨丰科技" "上市公司"） 元/股调整为 8.68 元/股，调整后的募集资金总额为 429,528,246.28 元。除 上述调整外，公司本次向特定对象发行 A 股股票的其他事项未发生变化。 一、公司 2024 年度权益分派实施情况 度利润分配方案的议案》，同意公司以实施权益分派股权登记日登记的总股本为 基数，向全体股东每 10 股派发现金红利 0.08 元（含税）。本次分红不进行资本 公积金转增股本，不送红股，剩余未分配利润结转以后年度。 润分配以方案实施前的公司总股本 169,007,951 股为基数，每股派发现金红利 记日为 2025 年 6 月 3 日，除权除息日为 2025 年 ...

Group 1 - The company, Hefei Fengle Seed Industry Co., Ltd., has received an inquiry letter from the Shenzhen Stock Exchange regarding its application for a specific stock issuance [1][2] - The company will respond to the inquiry letter and update the application documents accordingly, ensuring compliance with the requirements [1] - The issuance of stocks to specific objects is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, with uncertainties regarding the approval timeline [2] Group 2 - The company emphasizes the importance of timely information disclosure based on the progress of the stock issuance matter [2] - Investors are advised to make cautious decisions and be aware of investment risks associated with the stock issuance process [2]

Core Viewpoint - Tianfeng Securities has shown a positive stock performance with a recent increase in share price and significant shareholder activity, indicating potential growth and investor confidence in the company. Group 1: Stock Performance - As of June 6, 2025, Tianfeng Securities' stock closed at 3.98 yuan, up 2.05% from the previous week, with a weekly high of 4.03 yuan and a low of 3.88 yuan [1] - The current total market capitalization of Tianfeng Securities is 34.49 billion yuan, ranking 26th in the securities sector and 396th among all A-shares [1] Group 2: Shareholder Activity - Hubei Hongtai Group Co., Ltd. increased its holdings by 91.96 million shares from July 2, 2024, to May 30, 2025, representing 1.0612% of the total share capital, during which the stock price rose by 77.27% [2] - As of the announcement date, Hubei Hongtai Group has cumulatively increased its A-share holdings by 178,672,135 shares, accounting for 2.06% of the total share capital, with an investment amount of approximately 501.87 million yuan (excluding taxes) [2] Group 3: Government Subsidies - Tianfeng Securities' wholly-owned subsidiary received a government subsidy of 32.56 million yuan on May 30, 2025, which is 109.60% of the audited net profit attributable to shareholders for the fiscal year 2024, expected to positively impact the company's profits [3] Group 4: Upcoming Events - Tianfeng Securities will hold its 2024 annual shareholders' meeting on June 27, 2025, to discuss various reports and profit distribution plans [4] Group 5: Stock Issuance - Tianfeng Securities received approval from the China Securities Regulatory Commission for the registration of a stock issuance to specific investors, valid for 12 months from the date of approval [5]

Core Points - The company held its second special meeting of the fifth board of independent directors on June 6, 2025, to discuss and approve various proposals related to a simplified procedure for issuing shares to specific targets [1][2][3] Group 1: Approval of Share Issuance - The independent directors unanimously agreed that the company meets the conditions for issuing shares through a simplified procedure to specific targets, in accordance with relevant laws and regulations [2][3] - The proposal for the company's simplified share issuance plan was approved, aligning with the company's long-term development strategy and protecting shareholder interests [2][3] - The independent directors approved the 2025 annual plan for issuing shares through a simplified procedure, confirming its feasibility and alignment with the interests of all shareholders, especially minority shareholders [2][3] Group 2: Fund Allocation and Analysis - The independent directors approved the proposal regarding the allocation of funds raised through the share issuance, emphasizing that the funds will be directed towards technology innovation, enhancing the company's tech attributes [3][4] - A detailed analysis report justifying the share issuance plan was approved, covering the background, necessity, pricing principles, and feasibility of the issuance [4] - The feasibility analysis report for the use of raised funds was also approved, confirming that the plan aligns with national industrial policies and the company's strategic development [4] Group 3: Risk Management and Shareholder Returns - The independent directors reviewed and approved the risk management measures related to the potential dilution of immediate returns from the share issuance, ensuring that the interests of all shareholders are protected [4][5] - A three-year dividend return plan for shareholders from 2025 to 2027 was approved, aligning with legal regulations and the company's actual situation [5] - The report on the usage of previously raised funds was approved, confirming compliance with regulations and accurate reporting of fund usage [5][6] Group 4: Non-Recurring Gains and Losses - The independent directors approved the detailed report on non-recurring gains and losses for the last three years and the first quarter of 2025, ensuring accurate reflection of the company's financial situation [6]

Core Viewpoint - The document provides a supplementary legal opinion regarding the stock issuance by Guizhou Zhongyida Co., Ltd. to specific investors, confirming compliance with relevant laws and regulations [1][3][4]. Group 1: Legal Compliance - The issuance scale is not to exceed RMB 210 million, with Tianjin Xinjing as the designated investor [5][9]. - Tianjin Xinjing qualifies as an investor under the relevant regulations, being a controlled entity of the major shareholder [6][9]. - The subscription agreement specifies that Tianjin Xinjing will acquire up to 68,403,908 shares at a price of RMB 3.07 per share [8][9]. Group 2: Production Capacity and Compliance - The company has reported production capacities exceeding environmental assessment limits for several products, including pentaerythritol and food-grade alcohol, with utilization rates above 120% [9][12]. - The company has faced administrative penalties in the past, including a fine of RMB 20,000 for safety violations [10][21]. - Environmental and safety compliance has been confirmed by local authorities, indicating no significant violations or penalties since 2021 [18][19][21].

Core Viewpoint - The company plans to issue A-shares to specific investors in 2025, which may dilute immediate returns for existing shareholders, but it has proposed measures to mitigate this impact [1][5][9]. Impact on Earnings Per Share - The issuance is expected to increase the total share capital from 44,533.57 million shares to 48,986.93 million shares [2]. - In a scenario where the net profit attributable to shareholders decreases by 10%, the diluted earnings per share (EPS) would drop from 0.24 to 0.18 yuan [2]. - If the net profit remains flat compared to 2024, the diluted EPS would decrease from 0.24 to 0.20 yuan [4]. - In a scenario where the net profit increases by 10%, the diluted EPS would slightly decrease from 0.24 to 0.23 yuan [4]. Necessity and Reasonableness of the Issuance - The issuance aims to supplement working capital to support business growth, especially in the high-investment biopharmaceutical and vaccine sectors [5][6]. - Continuous R&D investment is crucial for maintaining competitive advantages, and the funds will support ongoing innovation [5][6]. - The issuance will help reduce operational and financial risks by improving the company's financial structure and liquidity [6]. Use of Proceeds - All proceeds from the issuance will be used to enhance working capital, accelerating the R&D process and enriching the product pipeline [6][7]. Measures to Mitigate Dilution of Immediate Returns - The company will manage the raised funds strictly according to legal regulations to ensure proper usage [7][8]. - A detailed plan for the use of funds will be implemented to enhance business development and market competitiveness [7]. - The company will improve governance and internal controls to protect investor interests and ensure efficient fund utilization [8]. - A profit distribution policy will be established to optimize returns for investors, with a commitment to cash dividends when conditions allow [8][9]. Commitments from Management - The board of directors and senior management have committed to ensuring the effectiveness of the proposed measures to mitigate dilution [9][10]. - The actual controller and major shareholders have also made commitments to not interfere with the company's management and to protect shareholder interests [10][11].

Group 1 - The company has reported the usage of funds raised from the issuance of convertible bonds, confirming that all funds have been utilized by March 31, 2025, and the special account for these funds has been closed [3][11]. - The total amount raised from the issuance of convertible bonds was RMB 420 million, with a net amount of RMB 411.1 million after deducting issuance costs [2]. - The company has not changed the investment projects funded by the raised capital, nor has there been any transfer or replacement of these projects [5][7]. Group 2 - The company has utilized idle funds for cash management, with a maximum of RMB 30 million approved for this purpose, ensuring it does not affect the construction of investment projects [8]. - The company has temporarily supplemented working capital with idle funds on several occasions, all of which have been returned to the special account by the specified deadlines [9][10][12]. Group 3 - The company has reported that the investment projects funded by the raised capital have achieved expected economic benefits, with no projects generating returns below the promised threshold [15][17]. - The company has not used any of the raised funds for share subscription [18]. Group 4 - The company plans to extend the validity period for the resolution to issue shares to specific targets for another 12 months, ensuring the continuity and effectiveness of the issuance process [23]. - The company has applied for a total credit limit of RMB 1.6 billion from various banks to meet its operational funding needs [24][26]. Group 5 - The company is focused on enhancing its capital strength through the issuance of shares, which aligns with national industrial policies and the company's strategic development [58]. - The company has established a robust management system for the raised funds to ensure compliance and effective use, aiming to enhance shareholder returns [64][66].

Core Viewpoint - The company has decided to adjust the total amount of funds to be raised through a specific issuance of A-shares, reducing it from 747.63 million yuan to 737.63 million yuan, with the net proceeds intended for enhancing liquidity and repaying debts [2][4][22]. Group 1: Meeting Resolutions - The company's board of directors held an emergency meeting on May 30, 2025, where they unanimously approved the adjustment of the fundraising scale [1][7]. - The board's decision to adjust the fundraising amount is within the authorization granted by previous shareholder meetings, thus not requiring further approval [3][9]. Group 2: Fundraising Details - The adjusted total fundraising amount (including issuance costs) is now capped at 737.63 million yuan, with the net proceeds to be used entirely for liquidity enhancement and debt repayment [2][8][14]. - The number of shares to be issued has been adjusted to a maximum of 252,613,560 shares due to the reduction in the fundraising amount [2][16][22]. Group 3: Related Party Transactions - The company signed a supplementary agreement with its controlling shareholder, Guangzhou Zhujiang Industrial Group Co., Ltd., regarding the share subscription, which is part of the related party transaction [5][20][27]. - The controlling shareholder holds 31.10% of the company's shares, making this transaction a related party transaction as per regulatory definitions [24][22]. Group 4: Financial Implications - The fundraising is expected to improve the company's capital strength and financial structure, thereby enhancing its competitive position in the market [29][36]. - The issuance is projected to lower the company's debt-to-asset ratio and optimize its financial structure, which is anticipated to benefit shareholders in the long run [29][36].

Core Viewpoint - Zhejiang Hars Vacuum Vessel Co., Ltd. is planning to issue ordinary shares to specific investors, with the aim of raising up to 754.90 million RMB for various projects, including the "Hars Future Intelligent Creation" project [5][9][10]. Group 1: Issuance Details - The company will issue domestic listed ordinary shares (A shares) with a par value of 1.00 RMB per share [6]. - The issuance will be conducted through a specific object issuance method, subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission (CSRC) [6][7]. - The issuance will target no more than 35 specific investors, including qualified institutional investors and other eligible entities [6][7]. Group 2: Financial Aspects - The total amount to be raised from this issuance is capped at 754.90 million RMB, with the net proceeds intended for specific projects after deducting issuance costs [9][10]. - The maximum number of shares to be issued will not exceed 30% of the company's total share capital prior to the issuance, amounting to no more than 139,880,319 shares [8][10]. Group 3: Approval and Authorization - The company's board of directors approved the issuance plan on March 5, 2025, and the relevant resolutions were passed at the shareholders' meeting on March 21, 2025 [5][11]. - The authorization for the issuance is valid for twelve months from the date of the shareholders' meeting [10]. Group 4: Shareholder Structure - As of December 31, 2024, the largest shareholder is Lü Qiang, holding 176,327,685 shares, which is approximately 37.81% of the total share capital [12][13]. - The top ten shareholders collectively hold a significant portion of the company's shares, with no major changes in the control structure during the review period [12][14]. Group 5: Business Operations - The company's main business remains focused on the research, design, production, and sales of various types of cup and pot products, with no changes reported during the review period [17][23]. - The company has obtained various necessary licenses and certifications, including high-tech enterprise certificates and industrial product production licenses, ensuring compliance with regulatory requirements [18][19][20].

Group 1 - The company, Zhejiang Hars Vacuum Vessel Co., Ltd., has received a second round inquiry letter from the Shenzhen Stock Exchange regarding its application for a specific object stock issuance [1][2] - The company has conducted a thorough study and response to the inquiries raised in the letter, updating its prospectus and related application documents accordingly [2] - The stock issuance is subject to approval from the Shenzhen Stock Exchange and registration by the China Securities Regulatory Commission, with uncertainties regarding the approval timeline [2] Group 2 - The company has disclosed updated financial data and other matters related to the inquiry response on April 22, 2025, on the Giant Tide Information Network [2] - The company emphasizes the importance of adhering to legal regulations and will fulfill its information disclosure obligations based on the progress of the matter [2][3]